For a cardiac patient experiencing pain, which of the following is NOT typically part of initial treatment?

For a cardiac patient experiencing pain, the use of insulin is not typically a part of the initial treatment strategy. The primary focus in managing a cardiac event, such as suspected myocardial infarction, centers on alleviating the patient's symptoms and stabilizing their condition.

Aspirin (ASA) is commonly administered as it helps to thin the blood and reduce the risk of further clotting. Nitroglycerin is used to relieve chest pain by dilating blood vessels, thereby improving blood flow to the heart. Gravol, which is an anti-nausea medication, may sometimes be administered if the patient is experiencing nausea associated with cardiac events.

Insulin, while important in managing patients with diabetes, is not considered a standard initial treatment for cardiac pain. It's generally indicated if the patient is hyperglycemic or diabetic and requires management of blood glucose levels, but it does not directly address the acute situation of cardiac pain. Thus, insulin is not part of the first-line treatment protocol in this context.